Abstract
BAF57 is a core subunit present in all mammalian SWI/SNF ATP-dependent chromatin remodeling complexes, which regulates important biological processes including gene transcription, DNA recombination, DNA repair, and DNA replication. Among other functions, BAF57 mediates the recruitment of SWI/SNF to sequence-specific transcription factors. Thus, BAF57 plays a crucial role in regulating estrogen-dependent gene expression and proliferation in human cell lines derived from breast tumors. Increasing genetic and biochemical evidences suggest that mutations in BAF57 or alterations in its expression could play an oncogenic role in the mammary gland. Here, we describe two novel mutations in the BAF57 gene found in a breast cancer patient. Both mutations originate premature stop codons, leading to truncated proteins, structurally similar to another BAF57 mutant previously found in a human cell line derived from a breast tumor (BT-549). The expression of these novel BAF57 mutants has abnormally high estrogen receptor alpha (ERα) coactivating potential, suggesting that they might be involved in the aberrant estrogen-dependent proliferation that occur in the majority of breast tumors that retain ERα expression. In addition, the mutations in BAF57 affect its functional interaction with the androgen receptor and ETS2, two transcription factors that play an important role in breast cell biology. Therefore, mutations in BAF57 could impinge on several oncogenic signaling pathways contributing to the origin and/or development of breast cancer.
References
Wang W, Chi T, Xue Y, Zhou S, Kuo A, Crabtree GR (1998) Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc Natl Acad Sci USA 95(2):492–498
Tsukiyama T (2002) The in vivo functions of ATP-dependent chromatin-remodelling factors. Nat Rev Mol Cell Biol 3(6):422–429. doi:10.1038/nrm828
Weissman B, Knudsen KE (2009) Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res 69(21):8223–8230. doi:10.1158/0008-5472.CAN-09-2166
Belandia B, Orford RL, Hurst HC, Parker MG (2002) Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes. EMBO J 21(15):4094–4103
Garcia-Pedrero JM, Kiskinis E, Parker MG, Belandia B (2006) The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J Biol Chem 281(32):22656–22664
Link KA, Burd CJ, Williams E, Marshall T, Rosson G, Henry E, Weissman B, Knudsen KE (2005) BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25(6):2200–2215
Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665–676
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y et al (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266(5182):120–122
Kiskinis E, Garcia-Pedrero JM, Villaronga MA, Parker MG, Belandia B (2006) Identification of BAF57 mutations in human breast cancer cell lines. Breast Cancer Res Treat 98(2):191–198
Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL, Parker MG (2005) Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 25(4):1425–1436
Higgins MJ, Wolff AC (2010) The androgen receptor in breast cancer: learning from the past. Breast Cancer Res Treat 124(3):619–621. doi:10.1007/s10549-010-0864-5
Somboonporn W, Davis SR (2004) Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25(3):374–388. doi:10.1210/er.2003-0016
Baker KM, Wei G, Schaffner AE, Ostrowski MC (2003) Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J Biol Chem 278(20):17876–17884. doi:10.1074/jbc.M209480200
Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, Creasap N, Thompson JC, Caserta E, Wang H, Chong JL, Naidu S, Wei G, Sharma SM, Stephens JA, Fernandez SA, Gurcan MN, Weinstein MB, Barsky SH, Yee L, Rosol TJ, Stromberg PC, Robinson ML, Pepin F, Hallett M, Park M, Ostrowski MC, Leone G (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461(7267):1084–1091. doi:10.1038/nature08486
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics CA. Cancer J Clin 60(5):277–300. doi:10.3322/caac.20073
Hartman J, Strom A, Gustafsson JA (2009) Estrogen receptor beta in breast cancer—diagnostic and therapeutic implications. Steroids 74(8):635–641. doi:10.1016/j.steroids.2009.02.005
Castellano I, Allia E, Accortanzo V, Vandone AM, Chiusa L, Arisio R, Durando A, Donadio M, Bussolati G, Coates AS, Viale G, Sapino A (2010) Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers. Breast Cancer Res Treat 124(3):607–617. doi:10.1007/s10549-010-0761-y
Turner DP, Findlay VJ, Moussa O, Watson DK (2007) Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem 102(3):549–559. doi:10.1002/jcb.21494
Redmond AM, Bane FT, Stafford AT, McIlroy M, Dillon MF, Crotty TB, Hill AD, Young LS (2009) Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence. Clin Cancer Res 15(6):2098–2106. doi:10.1158/1078-0432.CCR-08-1649
Chen J, Archer TK (2005) Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol 25(20):9016–9027. doi:10.1128/MCB.25.20.9016-9027.2005
Hah N, Kolkman A, Ruhl DD, Pijnappel WW, Heck AJ, Timmers HT, Kraus WL (2010) A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex. Cancer Res 70(11):4402–4411. doi:10.1158/0008-5472.CAN-09-2767
Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14(5):518–527. doi:10.1038/nm1764
Davis LM, Harris C, Tang L, Doherty P, Hraber P, Sakai Y, Bocklage T, Doeden K, Hall B, Alsobrook J, Rabinowitz I, Williams TM, Hozier J (2007) Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma. J Mol Diagn 9(3):327–336
Acknowledgments
This study was supported by the Ministerio de Ciencia e Innovación (SAF2007-62642 and SAF2010-21013), Instituto de Salud Carlos III (FIS CP05/00248) and the Fundación de Investigación Médica Mutua Madrileña. We thank Ana Aranda for her continuous support.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Ángeles Villaronga and I. López-Mateo contributed equally to this study and should be considered as co-first authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Villaronga, M.Á., López-Mateo, I., Markert, L. et al. Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient. Breast Cancer Res Treat 128, 891–898 (2011). https://doi.org/10.1007/s10549-011-1492-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-011-1492-4